Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature

Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature

Poorly differentiated cancers are a diagnostic and therapeutic challenge in oncology. New therapies are needed for patients with poorly differentiated thyroid carcinoma (PDTC) or anaplastic thyroid cancer, as these patients often present with advanced disease and effective systemic treatment options...

Full description

Bibliographic Details
Main Authors:	Hazel Lote, Jaishree Bhosle, Khin Thway, Kate Newbold, Mary O'Brien
Format:	Article
Language:	English
Published:	Karger Publishers 2014-06-01
Series:	Case Reports in Oncology
Subjects:	Poorly differentiated thyroid carcinoma Targeted therapy Epidermal growth factor mutation Tyrosine kinase inhibitors Erlotinib Intratumoural heterogeneity Poorly differentiated carcinoma Metastatic thyroid carcinoma
Online Access:	http://www.karger.com/Article/FullText/364856

Similar Items

Poorly Differentiated Thyroid Carcinoma: An Incubating Entity
by: Peter M. Sadow, et al.
Published: (2012-06-01)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
by: Bo Zhang, et al.
Published: (2016-01-01)

Poorly differentiated thyroid carcinoma: A hospital-based clinicopathological study and review of literature
by: Thin Thin Win, et al.
Published: (2017-01-01)

Poorly differentiated thyroid carcinoma
by: Sushama Guruwale, et al.
Published: (2015-01-01)

Poorly differentiated thyroid carcinoma arising in struma ovarii- a report of two extremely rare cases
by: Yadav Subhash, et al.
Published: (2020-09-01)

Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience
by: Besic Nikola, et al.
Published: (2015-09-01)

Long-term efficacy and safety of fourth-line multikinase inhibitor treatment with lenvatinib in a young papillary thyroid carcinoma patient
by: S. Morelli, et al.
Published: (2017-07-01)

Contribution of cytologic examination to diagnosis of poorly differentiated thyroid carcinoma
by: Na Rae Kim, et al.
Published: (2020-03-01)

Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
by: Anna Maria Malfitano, et al.
Published: (2019-10-01)

Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes
by: Burkey, B.B, et al.
Published: (2022)

Overview of the 2022 WHO Classification of Thyroid Neoplasms
by: Asa, S.L, et al.
Published: (2022)

Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
by: Valeria Pecce, et al.
Published: (2020-07-01)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
by: Klara Johansson, et al.
Published: (2021-08-01)

<i>NTRK</i> Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis
by: Barbora Pekova, et al.
Published: (2021-04-01)

Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report
by: Havva Sezer, et al.
Published: (2021-01-01)

Dynamic Contrast-Enhanced Computed Tomography Findings that may Predict Poorly-Differentiated Hepatocellular Carcinoma Prior to Treatment
by: Chananwat Manyanon, et al.
Published: (2020-04-01)

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum
by: Toyoshi Yanagihara, et al.
Published: (2021-01-01)

Thyroid Metastasis from Breast Carcinoma Accompanied by Papillary Thyroid Carcinoma
by: Song-I Yang, et al.
Published: (2014-07-01)

miR-19a Is Involved In Progression And Malignancy Of Anaplastic Thyroid Cancer Cells
by: Calabrese G, et al.
Published: (2019-11-01)

Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells
by: Hongxia Shang, et al.
Published: (2019-06-01)

Targeted therapy in patients with poor-prognosis renal cell carcinoma
by: B. Ya. Alekseev, et al.
Published: (2017-06-01)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
by: Joachim N. Nilsson, et al.
Published: (2021-07-01)

Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature—A New Goal for Early Diagnosis and Therapy?
by: Filippo Ricciardiello, et al.
Published: (2021-05-01)

Poorly differentiated clusters: prognostic significance in colorectal carcinomas
by: Aura Jurescu, et al.
Published: (2020-03-01)

Anaplastic Thyroid Cancer: Experience of the Philippine General Hospital
by: Tom Edward Lo, et al.
Published: (2015-06-01)

Metastasis of Poorly Differentiated Thyroid Carcinoma to the Sternum: A Case Report
by: Hae-Jung Kim, et al.
Published: (2020-07-01)

Post-surgical treatment of thyroid carcinoma in dogs with retinoic acid 9 cis improves patient outcome
by: V. Castillo, et al.
Published: (2016-01-01)

Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
by: Haihong Wang, et al.
Published: (2020-03-01)

Tubulocystic renal cell carcinoma with poorly differentiated foci and loss of fumarate hydratase: A case report
by: Turki O. Al-Hussain, et al.
Published: (2020-11-01)

Metastatic follicular carcinoma of thyroid in maxilla
by: Caliaperoumal Santhosh Kumar, et al.
Published: (2013-01-01)

Clinical profile of medullary thyroid carcinoma: Audit from a tertiary care center in South India
by: P R Manjunath, et al.
Published: (2020-01-01)

Post-surgical Thyroid Bed Pyoderma Gangrenosum Mimicking Recurrent Papillary Thyroid Carcinoma
by: Alessia Dolci, et al.
Published: (2019-04-01)

“Tumour sink effect” on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice
by: Sandip Basu, et al.
Published: (2020-01-01)

Questions and Approaches to the Choice of Surgical Treatment of the Differentiated Thyroid Cancer
by: I.R. Yanchiy, et al.
Published: (2013-10-01)

Die Prognose des differenzierten Schilddrüsenkarzinoms in Abhängigkeit von der zum Erreichen eines erkrankungsfreien Zustands benötigten Zahl der I-131-Therapien
by: Thies, Elena-Daphne Dorothée
Published: (2015)

Carcinoma diferenciado da tireóide na infância
by: Geraldo Matos de Sá, et al.

Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes
by: Jianing Tang, et al.
Published: (2018-03-01)

Which surgery needs to be used in the Differentiated Thyroid Carcinoma?
by: Antonella Pino, et al.
Published: (2018-12-01)

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)

A Closer Look at Papillary Thyroid Carcinoma
by: Won Bae Kim
Published: (2015-03-01)